Beta Drugs Limited (NSE:BETA)
India · Delayed Price · Currency is INR 1,502.90
-50.90 (-3.28%)
At close: Jan 23, 2026
Beta Drugs Market Cap
Beta Drugs has a market cap or net worth of 15.17 billion as of January 23, 2026. Its market cap has decreased by -21.03% in one year.
Market Cap
15.17B
Enterprise Value
15.40B
Revenue
3.86B
Ranking
n/a
PE Ratio
28.02
Stock Price
1,502.90
Market Cap Chart
Since October 25, 2017, Beta Drugs's market cap has increased from 915.98M to 15.17B, an increase of 1,556.27%. That is a compound annual growth rate of 40.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 15.17B | -2.98% |
| Dec 31, 2025 | 15.64B | -19.04% |
| Dec 31, 2024 | 19.31B | 36.67% |
| Dec 29, 2023 | 14.13B | 107.04% |
| Dec 30, 2022 | 6.83B | 10.89% |
| Dec 31, 2021 | 6.16B | 497.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharma Advanced Research Company | 41.54B |
| Innova Captab | 37.35B |
| RPG Life Sciences | 36.85B |
| Orchid Pharma | 35.54B |
| Solara Active Pharma Sciences | 25.05B |
| Indoco Remedies | 19.23B |
| Windlas Biotech | 16.86B |
| Jagsonpal Pharmaceuticals | 11.52B |